1. Home
  2. AAT vs IVA Comparison

AAT vs IVA Comparison

Compare AAT & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Assets Trust Inc.

AAT

American Assets Trust Inc.

HOLD

Current Price

$19.48

Market Cap

1.1B

Sector

Real Estate

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$6.72

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAT
IVA
Founded
1967
2011
Country
United States
France
Employees
208
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
AAT
IVA
Price
$19.48
$6.72
Analyst Decision
Hold
Strong Buy
Analyst Count
2
10
Target Price
$20.00
$16.20
AVG Volume (30 Days)
491.6K
463.2K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
7.21%
N/A
EPS Growth
N/A
N/A
EPS
0.92
N/A
Revenue
$436,204,000.00
N/A
Revenue This Year
$6.32
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.69
$2.70
52 Week High
$22.79
$7.98

Technical Indicators

Market Signals
Indicator
AAT
IVA
Relative Strength Index (RSI) 59.25 60.76
Support Level $17.80 $5.95
Resistance Level $19.32 $6.72
Average True Range (ATR) 0.45 0.28
MACD 0.08 -0.01
Stochastic Oscillator 85.50 86.14

Price Performance

Historical Comparison
AAT
IVA

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: